Wu M.-C.Huang W.-C.HO-HSIUNG LINHsiao S.-M.2021-03-032021-03-0320110015-0282https://www.scopus.com/inward/record.uri?eid=2-s2.0-79956338340&doi=10.1016%2fj.fertnstert.2011.01.165&partnerID=40&md5=644e761e84430997f148b8225a5caaa5https://scholars.lib.ntu.edu.tw/handle/123456789/550220Objective: To describe a case of severe intra-abdominal bleeding from omental implants after laparoscopic linear salpingostomy for ectopic pregnancy (EP). Design: Case report. Setting: A medical center. Patient(s): A 27-year-old woman, presenting 15 days after methotrexate (MTX) treatment for persistent EP (35 days after laparoscopic linear salpingostomy for EP). Intervention(s): Partial omentectomy. Main Outcome Measure(s): Serial β-hCG levels after partial omentectomy. Result(s): Histopathologic examination confirmed omental pregnancy. Her β-hCG levels decreased rapidly from 1,673 mIU/mL to 1.35 mIU/mL within 14 days after partial omentectomy. Conclusion(s): Persistent EP after laparoscopic linear salpingostomy can occur in the omentum; meticulous clinical follow-up should be performed, especially when IM MTX injection was used as the salvage treatment for persistent EP. ? 2011 by American Society for Reproductive Medicine.[SDGs]SDG3chorionic gonadotropin beta subunit; methotrexate; abdominal bleeding; adult; amenorrhea; article; case report; ectopic pregnancy; female; hemorrhagic shock; histopathology; human; human tissue; laparoscopic surgery; lower abdominal pain; omentectomy; omentum implant; outcome assessment; priority journal; salpingostomySevere intra-abdominal bleeding from neglected omental implantation of ectopic tissue after methotrexate treatment for persistent ectopic pregnancyjournal article10.1016/j.fertnstert.2011.01.1652-s2.0-79956338340